Skip to main content

Table 1 Clinicopathologic features of patients with positive vs. negative axillary US-FNA

From: Shortcomings of ultrasound-guided fine needle aspiration in the axillary management of women with breast cancer

VariablesPositive US-FNA [N(%)]Negative US-FNA [N(%)]
Average age52.53 ± 13.253 ± 11.1
Tumor type
 IDC39/65 (60)28/36 (77.8)
 IDC (residual)13/65 (20)0/36 (0)
 IDC-DCIS0/65 (0)1/36 (2.8)
 IDC/ILC0/65 (0)3/36 (8.3)
 ILC2/65 (3.1)2/36 (5.6)
 ILC (residual)1/65 (1.5)0/36 (0)
 DCIS1/65 (1.5)0/36 (0)
 DCIS (residual)1/65 (1.5)0/36 (0)
 Adenosquamous0/65 (0)1/36 (2.8)
 IMC with neuroendocrine features0/65 (0)1/36 (2.8)
 No residual6/65 (9.2)0/36 (0)
 No tumor1/65 (1.5)0/36 (0)
 NA1/65 (1.5)0/36 (0)
Modified SBR grade  
 (3/3)23/65 (35.4)19/36 (52.8)
 (2/3)23/65 (35.4)12/36 (33.3)
 (1/3)4/65 (6.2)3/36 (8.3)
 NA15/65 (23)2/36 (5.6)
 SizeMean = 3.4 +/- 3.3 cmMean = 2.3 ± 1.5 cm
 Median = 2.5 cmMedian = 2.0 cm
Neoadjuvant therapy
 None43/65 (66.2)33/36 (91.7)
 Yes21/65 (32.3)3/36 (8.3)
 NA1/65 (1.5)0/36 (0)
  1. US-FNA ultrasound-guided fine needle aspiration, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, DCIS ductal carcinoma in situ, IMC invasive mammary carcinoma, SBR Scarff-Bloom-Richardson, NA not available